Maaike de Fost - Concepedia

Author

Maaike de Fost

University of Amsterdam

Also Known As

M de Fost, M de Fost, M. De Fost, M. de Fost, M.de Fost, MAAIKE DE FOST, Maaike De Fost, Maaike de Fost

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Amsterdam UMC Location University of Amsterdam Udon Thani Hospital Mahidol University John Radcliffe Hospital

About

Maaike de Fost is an author at University of Amsterdam specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	401
2	Health Sciences	3	3	176
3	Public Health	2	2	222
4	Diabetes	2	2	90
5	Endocrinology	1	1	28

Maaike de Fost

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention Rolf G. Boot, Marri Verhoek, Maaike de Fost, Blood	2003	333
Increased incidence of cancer in adult Gaucher disease in Western Europe Maaike de Fost, Stephan vom Dahl, Gerrit Jan Weverling, Blood Cells Molecules and Diseases Cancer EpidemiologyGlobal HealthWestern EuropeEpidemiology Of CancerInternational Health	2005	180
Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis Maaike de Fost, Carla E. M. Hollak, J.E.M. Groener, Blood	2006	143
Increased plasma macrophage inflammatory protein (MIP)-1α and MIP-1β levels in type 1 Gaucher disease Mariëlle J. van Breemen, Maaike de Fost, Jane S.A. Voerman, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease InflammationType 1Gaucher DiseasePathogenesisImmunology	2007	112
Plasma level of the macrophage‐derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease Holger Jon Møller, Maaike de Fost, Carla E. M. Hollak, European Journal Of Haematology	2004	105
Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature Maaike de Fost, T. A. Out, F. A. de Wilde, Annals of Hematology	2008	97
Recommendations for the management of the haematological and onco‐haematological aspects of Gaucher disease<sup>1</sup> Derralynn Hughes, Maria Domenica Cappellini, Marc Berger, British Journal of Haematology ImmunohematologyType 1Laboratory HematologyImmunoglobulin AbnormalitiesClinical Epidemiology	2007	86
Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy Mirjam Langeveld, Maaike de Fost, Johannes M. F. G. Aerts, Blood Cells Molecules and Diseases ObesityMetabolic SyndromeNutritionInsulin ResistanceDiabetes Management	2007	62
Differential expression of interferon-γ and interferon-γ-inducing cytokines in Thai patients with scrub typhus or leptospirosis Wirongrong Chierakul, Maaike de Fost, Yupin Suputtamongkol, Clinical Immunology CytokineImmunodeficienciesPathogenesisImmunologyScrub Typhus	2004	50
Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease Maaike de Fost, Mirjam Langeveld, Remco Franssen, Atherosclerosis Gaucher DiseaseCardiovascular DiseaseCardiometabolic RiskGlobal HealthHyperlipidemia	2008	42

Page 1